Intelligent Bio Solutions Inc. (INBS), a medical technology company, on Wednesday announced a significant partnership with Quantum Traffic Management or Quantum TM, a UK-based traffic management provider, to implement its Intelligent Fingerprinting Drug Testing Solution across 10 nationwide sites.
Quantum TM, with over 30 years of industry experience, previously relied on external testing providers but faced delays and inefficiencies.
INBS' technology enables quicker, on-the-spot drug screening, offering a more efficient and hygienic alternative.
This adoption expands INBS' portfolio, which now includes over 400 accounts worldwide.
The company plans to enter the US market in 2025, following its FDA 510(k) submission in December 2024.
The company's fingerprint-based drug screening system is gaining traction in sectors like construction, manufacturing, and transport.
Currently, INBS is trading at $1.42 down by 1.39%.
For comments and feedback: editorial@rttnews.com